Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 1 of 11 pages 1 2 3 > Last ›
HSL20489
Miller C, Clark B
Medicine ads misleading say lobby group
The Herald 1989 Dec 13
HSL9521
Conlan MF.
Drug industry must hold down Medicaid costs or states will
Drug Topics 1989 Dec 11; 133:48
HSL19886
Randall H
Drug Promotional Problem Dec 1989
MJA 1989 Dec; 151:(532):653
HSL3984
Wade VA, Mansfield PR, McDonald PJ.
Drug companies' evidence to justify advertising.
Lancet 1989 Nov 25; 2:(8674):1261-3
HSL15824
Rodwin MA.
Physicians' conflicts of interest. The limitations of disclosure
NEJM 1989 Nov 16; 321:(20):1405-1408
http://content.nejm.org/cgi/content/brief/321/20/1405
HSL19911
SKF Withdraws APMA Resignation
Australian Pharmaceutical Manufacturers Association 1989 Nov 10
HSL4021
Wilkes MS, Shuchman M.
Pitching doctors.
N Y Times Mag 1989 Nov 5; 88, 90, 126, 128-129
HSL4019
MaLAM letter follow up—Merck Sharp & Dohme. Are MSD’s distributors uncontrollable?
MaLAM Newsletter 1989 Nov;
HSL4020
Re: the promotion of uridine triphosphate
1989 Nov;
HSL9519
Prescription drugs: ready for prime time?
National Association of Retail Druggists Journal 1989 Nov; 111:26-27, 29-30
HSL9520
West CM.
Independent retail pharmacy in a free-market economy
National Association of Retail Druggists Journal 1989 Nov; 111:54-57
HSL19912
Margo J
APMA withdraws news release
The Sydney Morning Herald 1989 Oct 307
HSL19910
Margo J
Drug Firm Quits After Findings on Complaints
The Sydney Morning Herald 1989 Oct 267
http://newsstore.smh.com.au/apps/viewDocument.ac?page=1&sy=smh&kw=Drug+firm+quits+after+findings+on+complaints&pb=smh&dt=selectRange&dr=entire&so=relevance&sf=text&sf=headline&rc=10&rm=200&sp=nrm&clsPage=1&docID=news891025_0291_2188
HSL4017
Cearnal ME.
Journal advertising works
Medical Marketing & Media 1989 Oct 20; 24:(12):4,6-10
HSL20484
MaLAM's open letter to industry
Scrip 1989 Oct 20; (1457):22
HSL4013
Re: the promotion of DPT-P vaccine
1989 Oct;
HSL4014
MaLAM letter follow up—Wellcome: a welcome withdrawal
MaLAM Newsletter 1989 Oct;
HSL4015
Re: the promotion of Franol combination for asthma
1989 Oct;
HSL9516
Gervas JJ.
Analysis of the factors inducing the prescription
Farmacia Clinica 1989 Oct; 6:588-590, 592-594
HSL9518
Johnson RC.
Seeking sanity in an insane world
California Pharmacist 1989 Oct; 37:24, 26-27
HSL9537
Zellmer WA.
Generic drug products.
Am J Hosp Pharm 1989 Oct; 46:(10):2005
HSL16719
Wolfe SM.
The right to know belatedly comes to the health care system.
Internist 1989 Oct; 30:(9):12-4
http://www.ncbi.nlm.nih.gov/pubmed/10295873
HSL3962
Lexchin J.
Declaration of vested interest.
Lancet 1989 Sep 30; 2:(8666):806
HSL3936
Engler RL.
The arrhythmia consultation program.
N Engl J Med 1989 Sep 28; 321:(13):908
HSL20485
Lexchin J
Drug economics in developing countries
The Lancet 1989 Sep 16;
HSL3953
Jarman J.
SKF marketing of hepatitis B vaccine.
N Z Med J 1989 Sep 13; 102:(875):481
HSL3954
Kawachi I.
Fenoterol.
N Z Med J 1989 Sep 13; 102:(875):478
HSL5287
Borgiel AE, Dunn EV, Lamont CT, MacDonald PJ, Evensen MK, Bass MJ, Spasoff RA, Williams JI.
Recruiting family physicians as participants in research.
Fam Pract 1989 Sep 01; 6:(3):168-72
HSL9525
Hearing blasts drug manufacturers' emphasis on R&D for me too drugs
American Pharmacy 1989 Sep; 29:16
HSL9526
Exposing the inequities: Senate hearing examines prescription drug prices
National Association of Retail Druggists Journal 1989 Sep; 111:30-36
HSL9527
Levy RA, Smith DL.
Staying the course: refill reminders can boost sales
Pharmaceutical Executive 1989 Sep; 9:74, 76, 78
HSL9528
Koberstein W.
Pitching to new players
Pharmaceutical Executive 1989 Sep; 9:12
HSL9529
Schwartz H.
Docs, Danes and dogs: sampler for the industry
Pharmaceutical Executive 1989 Sep; 9:18, 20
HSL9530
Bamberger DR.
Industry responds to new law on drug diversion
Pharmaceutical Executive 1989 Sep; 9:100, 102, 104, 106
HSL3980
Spiro M.
Genentech, Inc, and symposium sponsorship.
Ann Emerg Med 1989 Aug; 18:(8):908-9
HSL4010
Children’s vitamin preparations: kidding the kids and their parents
1989 Aug; 4:(8):109-110
HSL4011
Re: the promotion of serrapeptase
1989 Aug;
HSL4012
Greenwood J.
Prescribing and salesmanship
HAI News 1989 Aug; (48):1-2, 11
HSL9509
Marsh P.
Prescribing for medical and other headaches
Eastern Pharmacist 1989 Aug; 32:63-65
HSL9517
Gagnon JP.
Defining and marketing value-added pharmacy services in a community pharmacy. Part 1
Pharmacy Times 1989 Aug; 55:61-62, 66-67
HSL9539
Nonprescription drug industry urges more prescription-to-nonprescription switches
American Journal of Hospital Pharmacy 1989 Aug; 46:1512
HSL13305
Rao AR, Monroe KB.
The Effect of Price, Brand Name, and Store Name on Buyers' Perceptions of Product Quality : An Integrative Review.
Journal of Marketing Research 1989 Aug; 26:(3):351-357
http://web.archive.org/web/20080510112957/http://www.marketingpower.com/content17866.php
HSL3955
Kiatboonsri P, Richter J.
Dipyrone trials in Thailand.
Lancet 1989 Jul 8; 2:(8654):107
HSL9532
McLeod DC.
Nonprescription drug approval: therapeutic strategy or marketing decision?
DICP 1989 Jul-Aug; 23:(7-8):606-9
HSL3979
Solomon SD.
We need ethical guidelines for promotion of prescription drugs to physicians.
N Engl J Med 1989 Jun 22; 320:(25):1700
HSL3961
Lexchin J.
Advertising drugs to the public.
Lancet 1989 Jun 17; 1:(8651):1392-3
HSL3978
Scott HV, Ketelbey JW.
Lederfen-F GP trial.
N Z Med J 1989 Jun 14; 102:(869):299-300
HSL3966
Massam D.
Promotion of medicines.
Lancet 1989 Jun 10; 1:(8650):1330
HSL4006
MaLAM letter follow-up—Merck Sharp & Dohme. Denial of responsibility
MaLAM Newsletter 1989 Jun;
HSL4007
Re: the promotion of tetracycline syrups for children
1989 Jun;
HSL4009
Re: the promotion of buflomedil
1989 Jun;
HSL9535
Schwartz H.
Prescriptions for profit: muckraking journalism on the PBS frontline
Pharmaceutical Executive 1989 Jun; 9:14, 16, 18
HSL9546
Manasse HR Jr.
Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2.
Am J Hosp Pharm 1989 Jun; 46:(6):1141-52
HSL857
Mansfield PR.
Drug advertising.
Lancet 1989 May 20; 1:(8647):1137-8
HSL3977
Schwartz TB.
Endorsement of "patient promise" program.
N Engl J Med 1989 May 18; 320:(20):1354-5
HSL4005
Miller A, Barrett T, Bradburn E.
Pitching to patients
1989 May 8; 40-41
HSL4002
IFPMA marketing code in new booklet, available in three languages
Health Horizons 1989 May;
HSL4003
Re: the promotion of nicergoline
1989 May;
HSL4004
Drug utilization bibliography
1989 May;
HSL9523
Schwartz H.
To prescribe or not? Essential and excessive use of pharmaceuticals
Pharmaceutical Executive 1989 May; 9:14, 16, 18
HSL9542
McLaughlin SS.
Novel promotional activities, direct-to-consumer advertising subjects of FDA scrutiny
American Journal of Hospital Pharmacy 1989 May; 46:870, 875
HSL3951
Holden C.
Research group forswears financial ties to firms whose drugs it tests.
Science 1989 Apr 21; 244:(4902):282
HSL19885
Randall H
Drug Promotion Problems
MJA 1989 Apr 17; 150:(531):463
HSL4000
Humphrey AR.
Treatment of herpes zoster.
N Z Med J 1989 Apr 12; 102:(865):168
HSL3975
Relman AS.
Economic incentives in clinical investigation.
N Engl J Med 1989 Apr 6; 320:(14):933-4
HSL3999
Healy B, Campeau L, Gray R, Herd JA, Hoogwerf B, Hunninghake D, Knatterud G, Stewart W, White C.
Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery.
N Engl J Med 1989 Apr 6; 320:(14):949-51
HSL3998
Moulds RF, Wing LM.
Drug advertising.
Med J Aust 1989 Apr 3; 150:(7):410-1
HSL3995
This month’s MaLAM letter—Glaxo. Multiple claims, little improvement
MaLAM Newsletter 1989 Apr;
HSL3996
Logarta JD.
Generics revisited: an overdose of expectations
Drug Monitor 1989 Apr; 4:(4):49-54
HSL3997
Vreeland LN.
The selling of Retin-A
Money 1989 Apr; 75-80, 84, 87
HSL9536
Weiner JN.
Direct advertising of prescription drugs to consumers
Pennsylvania Pharmacist 1989 Apr; 70:140-141
HSL9538
Cramer PK.
States' substitution laws squeeze industry innovators
Pharmaceutical Executive 1989 Apr; 9:74, 76, 78, 80
HSL3994
Prescriptions for profit
1989 Mar 28;
HSL3934
Dixon RE.
Medical advice by celebrities.
N Engl J Med 1989 Mar 16; 320:(11):742
HSL3948
Heery PJ.
What influences prescribing--scientific articles or promotional pressure?
Med J Aust 1989 Mar 6; 150:(5):282,
HSL9544
Rosendahl I.
Warner-Lambert readies Rx/OTC product launches
Drug Topics 1989 Mar 6; 133:75
HSL20218
Balla JI, Elstein AS, Christensen C
Obstacles to acceptance of clinical decision analysis.
BMJ 1989 Mar 4; 298:(6673):579–582
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1835917/
HSL3949
Helwig D.
There's no room for freebies in medical journalism.
CMAJ 1989 Mar 1; 140:(5):542-3
HSL3983
Thomas J 3rd.
National survey of recent changes in hospital policies on pharmaceutical sales representatives' activities.
Am J Hosp Pharm 1989 Mar; 46:(3):565-9
HSL9514
What will influence the growth of OTC drug sales?
Pharmacy Times 1989 Mar; 55:82, 85-86
HSL9541
Madhaven S.
On-going dilemma of direct to consumer advertising of Rx drugs
W Va Pharm 1989 Mar; 13:8-10
HSL9545
Tootelian DH.
Establishing a market niche: meeting the competitive challenge
American Pharmacy 1989 Mar; 29:61-69
HSL9555
Rx drugs and the information explosion
American Druggist 1989 Mar; 197:50
HSL9561
Louis WJ.
Conflict over drug policy in Australia.
BMJ 1989 Feb 25; 298:(6672):472-3
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=2495072
HSL3956
Kolbe J, Bai TR.
High-dose inhaled corticosteroids.
N Z Med J 1989 Feb 22; 102:(862):85
HSL1776
Ferguson RP.
Training the resident to meet the detail men.
JAMA 1989 Feb 17; 261:(7):992-3
HSL3990
MaLAM letter follow up—Abbott
MaLAM Newsletter 1989 Feb; 1
HSL3991
Re: the promotion of ketoconazole
1989 Feb;
HSL3992
George RA.
Direct drag promotion does not benefit patients.
J Fla Med Assoc 1989 Feb; 76:(2):239-40
HSL3993
Sarkar PK, Das SK.
Practitioners' obligation: to the public or the drug industry?
DICP 1989 Feb; 23:(2):175-6
HSL9540
Benoliel DM.
Original pack dispensing: dream or a reality?
Manufacturing-Chemist 1989 Feb; 60:39-40, 42
HSL14670
McQuaig L.
Accepting drug company perks is conflict of interest, MDs told
The Globe and Mail 1989 Jan 31
HSL3668
Birley JL.
Drug advertisements in developing countries.
Lancet 1989 Jan 28; 1:(8631):220
HSL3935
Duffin JM.
Junk mail.
CMAJ 1989 Jan 15; 140:(2):112
HSL9560
Guideline labeling texts for progestational drug products for human use
Federal Register 1989 Jan 12; 54:1243-1244
HSL3988
Highlights of a survey of Southeast Asian physicians
Drug Monitor 1989 Jan; 4:(1):8
HSL3989
MaLAM letter follow up—Last gasps for a respiratory stimulant
MaLAM Newsletter 1989 Jan; 1
HSL9534
Horvath D.
Problems raised by the necessity of combining preparates of the pharmaceutical industry into magistral prescriptions
Gyogyszereszet 1989 Jan; 33:3-4
HSL9548
Worthen DB.
One price for all.
Am Pharm 1989 Jan; NS29:(1):8
HSL9549
Work DR.
It's time to take the next step.
Am Pharm 1989 Jan; NS29:(1):22-3
Page 1 of 11 pages 1 2 3 > Last ›
